The potential benefits of dietary and/or supplemental calcium and vitamin D

Urologic Oncology: Seminars and Original Investigations

Volumn 21, Issue 5, 2003, Pages 384-391

  Moyad, Mark A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Calcium; Cancer; Cholesterol; Colon cancer; Diabetes; Dietary supplements; Hypertension; Kidney stones; Obesity; Osteoporosis; Premenstrual syndrome; Tooth loss; Vitamin D

Indexed keywords

ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM CARBONATE; CHOLESTEROL; ESTROGEN RECEPTOR; FLUORIDE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; PLACEBO; VITAMIN D;

ADENOMA; BLOOD PRESSURE; CALCIUM INTAKE; CANCER RISK; CARDIOVASCULAR DISEASE; COLON POLYP; COLORECTAL CANCER; COMMERCIAL PHENOMENA; CONFERENCE PAPER; DENTAL HEALTH; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG RESPONSE; FRACTURE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NEPHROLITHIASIS; OBESITY; OSTEOPOROSIS; PATIENT EDUCATION; PERIODONTAL DISEASE; PHYSICIAN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZATION; RECURRENT DISEASE; RISK; RISK REDUCTION; SAFETY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

ADULT; AGED; CALCIUM; COLONIC NEOPLASMS; DIABETES MELLITUS; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION; KIDNEY; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; OSTEOPOROSIS; VITAMIN D;

EID: 2042522691     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(03)00108-X     Document Type: Conference Paper

References (70)

1. Ray N.F., Chan J.K., Tharner M., et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995 report from the National Osteoporosis Foundation. J Bone Min Res. 12:1997;24-35
2. Schneider E.L., Guralnik J.M. The aging of America impact on health care costs. JAMA. 263:1990;2335-2340
3. Looker A.C., Orwoll E.S., Johnston C.C., et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Min Res. 12:1997;1761-2768
4. Maillefert J.F., Sibilia J., Michel F., et al. Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostate carcinoma. J Urol. 161:1999;1219-1222
5. Townsend M.F., Sanders W.H., Northway R.O., et al. Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma. Cancer. 79:1997;545-550
6. Bilezikian J.P. Osteoporosis in men. J Endocrinol Metab. 84:1999;3431-3434
7. Pfeilschifter J., Diel I.J. Osteoporosis due to cancer treatment pathogenesis and management. J Clin Oncol. 18:2000;1570-1593
8. Brown J.P., Josse R.G. for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 167:(suppl 10):2002;S1-S34
9. Moyad M.A. The ABCs of Nutrition and Supplements for Prostate Cancer. 2000;Sleeping Bear Press, Chelsea, MI
10. Lips R., Graafmans W., Ooms M.E., et al. Vitamin D supplementation and fracture incidence in elderly persons a randomized placebo-controlled clinical trial. Ann Int Med. 124:1996;400-406
11. Trivedi D.P., Doll R., Khaw T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community randomised double blind controlled trial. Br Med J. 326:2003;469-472
12. 3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 85:2000;3011-3019
13. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of calcium supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 337:1997;670-676
14. Suzuki Y., Oishi Y., Yamazaki H., et al. How to avoid bone loss in patients with prostatic carcinoma receiving long-term LHRH-analogue. J Urol. 163:(abstract 707):2000;159
15. Giovannucci E., Rimm E.B., Wolk A., et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res. 58:1998;442-447
16. Schuurman A.G., Van den Brandt P.A., Dorant P.A., et al. Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study. Br J Cancer. 80:1999;1107-1113
17. Yang C.Y., Chiu H.F., Tsai S.S., et al. Calcium and magnesium in drinking water and risk of death from prostate cancer. J Toxicol Environ Health. 60:2000;17-26
18. Berndt S.I., Carter H.B., Landis P.K., et al. Calcium intake and prostate cancer risk in a long-term aging study the Baltimore Longitudinal Study of Aging. Urology. 60:2002;1118-1123
19. Gross C., Stamey T., Hancock S., et al. Treatment of early recurrent prostate cancer with 1, 25-dihydroxyvitamin D3 (calcitriol). J Urol. 159:1998;2035-2039
20. Van Veldhuizen P.J., Taylor S.A., Williamson S., et al. Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. J Urol. 163:2000;187-190
21. Beer T.M., Eilers K.M., Garzotto M., et al. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol. 21:2003;123-128
22. Smith M.R., McGovern F.J., Zietman A.L., et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med. 345:2001;948-955
23. Orwoll E., Ettinger M., Weiss S., et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 343:2000;604-610
24. Vedral J.L. Standing committee on the Scientific Evaluation of Dietary Reference Intakes, Institute of Medicine, Dietary Reference Intakes Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. 1997;National Academy Press, Washington, DC
25. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., et al. Hypovitaminosis D in medical inpatients. New Engl J Med. 338:1998;777-783
26. Govers M.J.A.P., Vandermeer R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut. 34:1993;365-370
27. Carlson L.A., Olsson A.G., Oro L., Rossner S. Effects of oral calcium on serum cholesterol and triglycerides in patients with hyperlipidemia. Atherosclerosis. 14:1971;391-400
28. Reid I.R., Mason B., Horne A., et al. Effects of calcium supplementation on serum lipid concentrations in normal older women a randomized controlled trial. Am J Med. 112:2002;343-347
29. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389
30. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholeterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 333:1995;1301-1307
31. Bostick R.M., Kushi L.H., Wu Y., et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 149:1999;151-161
32. Giovannucci E., Stampfer M.J., Colditz G., Rimm E.B., Willett W.C. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst. 84:1992;91-98
33. Lipkin M., Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 313:1985;1381-1384
34. Janne P.A., Mayer R.J. Chemoprevention of colorectal cancer. N Engl J Med. 342:2000;1960-1968
35. Burke C.A., Bauer W.M., Lashner B. Chemoprevention of colorectal cancer slow, steady progress. Cleveland Clinic J Med. 70:2003;346-350
36. Baron J.A., Beach M., Mandel J.S., et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med. 340:1999;101-107
37. Bonithon-Kopp C., Kronborg O., Giacosa A., Rath U., Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet. 356:2000;1300-1306
38. Pignone M., Levin B. Recent developments in colorectal cancer screening and prevention. Am Fam Phys. 66:2002;297-302
39. Miller G.D., Anderson J.J.B. The role of calcium in prevention of chronic diseases. J Am Coll Nutr. 18:1999;371S-372S
40. Lipkin M., Newmark H.L. Vitamin D, calcium and prevention of breast cancer a review. J Am Coll Nutr. 18:1999;392S-397S
41. Holt P.R., Arber N., Halmos B. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomark Prev. 11:2002;113-119
42. Tedeschi-Blok N., Schwartzbaum J., Lee M., Miike R., Wrensch M. Dietary calcium consumption and astrocytic glioma The San Francisco Bay Area Adult Glioma Study, 1991-1995. Nutr Cancer. 39:2001;196-203
43. Krall E.A., Wehler C., Garcia R.I., Harris S.S., Dawson-Hughes B. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med. 111:2001;452-456
44. Saggese G., Frederico G., Balestri M., Torriolo A. Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J Endocrinol Invest. 12:1989;329-335
45. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrinol Rev. 15:1994;516-542
46. Mathieu C., Waer M., Laureys J., Rutgeerts O., Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin D3. Diabetologia. 37:1994;552-558
47. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia. 42:1999;51-54
48. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 338:1998;777-783
49. Stene L.C., Ulriksen J., Magnus P., Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia. 43:2000;1093-1098
50. Hypponen E., Laara E., Reunanen A., Jarvelin M.-R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes a birth-cohort study. Lancet. 358:2001;1500-1503
51. Zemel M.B. Calcium modulation of hypertension and obesity mechanisms and implications. J Am Coll Nutr. 20:2001;428S-435S
52. McCarron D.A., Morris C., Cole C. Dietary calcium in human hypertension. Science. 217:1982;267-269
53. McCarron D.A., Morris C.D., Henry H.J., Stanton J.L. Blood pressure and nutrient intake in the United States an analysis of the Health and Nutrition Examination Survey I. Science. 224:1984;1392-1398
54. Bucher H.C., Cook R.J., Guyatt G.H., et al. Effects of dietary calcium supplementation on blood pressure a meta-analysis of randomized controlled trials. JAMA. 275:1996;1016-1022
55. Bucher H.C., Guyatt G.H., Cook R.J., et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia a meta-analysis of randomized controlled trials. JAMA. 275:1996;1113-1117
56. McCarron D.A., Reusser B.A. Finding consensus in the dietary calcium-blood pressure debate. J Am Coll Nutr. 18:1999;398S-405S
57. Appel L.J., Moore T.J., Obarzanek E., et al. DASH Collaborative Research Group a clinical trial of the effects of dietary patterns on blood pressure. New Engl J Med. 336:1997;1117-1124
58. Ramello A., Vitale C., Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 13:(suppl 3):2000;S45-S50
59. Bushinsky D.A. Nephrolithiasis. J Am Soc Nephrol. 9:1998;917-924
60. Bushinsky D.A. Recurrent hypercalciuric nephrolithiasis-does diet help? N Engl J Med. 346:2002;124-125
61. Lemann J. Jr, Pleuss J.A., Worcester E.M., et al. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Intl. 49:1996;200-208
62. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 328:1993;833-838
63. Borghi L., Schianchi T., Meschi T., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 346:2002;77-84
64. Zemel M.B., Shi H., Greer B., DiRienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. Fed Am Soc Exp Biol J. 14:2000;1132-1138
65. Okey R., Stewart J.A., Greenwood M.L. Studies of the metabolism of women. IV. The calcium and inorganic phosphorus in the blood of normal women at the various stages of the monthly cycle. J Biol Chem. 87:1930;91-102
66. Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutr. 19:2000;3-12
67. Thys-Jacobs S., Starkey P., Bernstein D., Tian J. the Premenstrual Syndrome Study Group. Calcium carbonate and the premenstrual syndrome effects of premenstrual and menstrual symptoms. Am J Obstet Gynecol. 179:1998;444-452
68. Hegsted D.M. Fractures, calcium, and the modern diet. Am J Clin Nutr. 74:2001;571-573
69. Reid D.M., Macdonald H.M. Nutrition and bone is there more to it than just calcium and vitamin D? Q J Med. 94:2001;53-56
70. Hegsted D.M. Calcium and osteoporosis. J Nutr. 116:1986;2316-2319